News

The Role of Molecular Testing in the Diagnosis of Cutaneous Soft Tissue Tumors

This review will focus on select cutaneous mesenchymal neoplasms with known molecular hallmarks that are useful diagnostically.


 

Alison L. Cheah, MBBS, and Steven D. Billings, MD

A number of soft tissue tumors are characterized by recurring genetic abnormalities. The identification of these abnormalities has advanced our understanding of the biology of these tumors and has led to the development of molecular tests that are helpful diagnostically. This review will focus on the application of molecular diagnostic testing in select mesenchymal tumors of the dermis and subcutis.

*For a PDF of the full article, click on the link to the left of this introduction.

Recommended Reading

Imaging Unwarranted in Primary Cutaneous Melanoma
MDedge Dermatology
Merkel Cell Carcinoma Prognosis Linked to Vitamin D
MDedge Dermatology
Melanoma Treatment With Vemurafenib Can Trigger Leukemia
MDedge Dermatology
Innovative Methods of UV Protection
MDedge Dermatology
There's No Place for 'Dabbling' in Mohs Surgery
MDedge Dermatology
Molecular Platforms Utilized to Detect BRAF V600E Mutation in Melanoma
MDedge Dermatology
Molecular Diagnosis of Infection-Related Cancers in Dermatopathology
MDedge Dermatology
The Role of Molecular Analysis in Cutaneous Lymphomas
MDedge Dermatology
Molecular Diagnostics for Ambiguous Melanocytic Tumors
MDedge Dermatology
Broad-Spectrum Moisturizer Effectively Prevents Molecular Reactions to UVA Radiation
MDedge Dermatology